GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma
Cells · 2024
DOI: 10.3390/cells13242128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Dong-Gun Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Targeted Therapy Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Neoplasm Metastasis, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Center.
Abstract (Originalsprache)
Metastasis is a leading cause of lung adenocarcinoma (LUAD)-related mortality and presents significant challenges for treatment. The gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor (GPCR) family, has an unclear role in LUAD progression. This study aimed to investigate the function and underlying mechanisms of GRPR in LUAD metastasis. Our findings revealed that GRPR levels were significantly elevated in tumor tissues, and higher GRPR expression was associated with worse overall survival outcomes. Functional assays demonstrated that GRPR overexpression enhanced LUAD cell invasion, while GRPR knockdown inhibited invasion both in vitro and in vivo. RNA sequencing and gene set enrichment analysis (GSEA) identified an enrichment of metastasis-promoting genes in GRPR-overexpressing cells, with CRABP2 and FNDC4 emerging as key targets. Clinical analyses further confirmed a positive correlation between GRPR expression and the levels of CRABP2 and FNDC4 in LUAD patients. These results suggest that GRPR could serve as both a prognostic marker and a therapeutic target to inhibit metastasis in LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Targeted Therapy Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.
Förderung
- National Cancer Center
Zitieren
APA
Kim, D. G., Choi, E. Y., Ahn, H. M., & Kim, Y. J. (2024). GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma. Cells. https://doi.org/10.3390/cells13242128
Vancouver
Kim DG, Choi EY, Ahn HM, Kim YJ. GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma. Cells. 2024. doi:10.3390/cells13242128
BibTeX
@article{Kim2024,
author = {Kim, Dong-Gun and Choi, Eun-Young and Ahn, Hye-Mi and Kim, Youn-Jae},
title = {GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13242128}
}
EUVIMED